2021
DOI: 10.1007/s00204-020-02946-5
|View full text |Cite
|
Sign up to set email alerts
|

Chronic senescent human mesenchymal stem cells as possible contributor to the wound healing disorder after exposure to the alkylating agent sulfur mustard

Abstract: Wound healing is a complex process, and disturbance of even a single mechanism can result in chronic ulcers developing after exposure to the alkylating agent sulfur mustard (SM). A possible contributor may be SM-induced chronic senescent mesenchymal stem cells (MSCs), unable to fulfil their regenerative role, by persisting over long time periods and creating a proinflammatory microenvironment. Here we show that senescence induction in human bone marrow derived MSCs was time- and concentration-dependent, and ch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 66 publications
0
8
0
Order By: Relevance
“…Notably, senescent hMSCs were found to be resistant towards other senolytic compounds. Indeed, by analyzing the existing evidence we found that various compounds with the stated senolytic activity, including navitoclax, nicotinamide riboside, danazol geldanamycin, ganetespib, fisetin, BCL-XL inhibitors, quercetin, etomoxir, antimycin A, FOXO4-DRI, 17-DMAG turned to be ineffective for the targeted removal of senescent human preadipocytes (fibroblast like precursor cells derived from human adipose tissue) and hMSCs from bone marrow [ 17 19 , 36 , 40 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Notably, senescent hMSCs were found to be resistant towards other senolytic compounds. Indeed, by analyzing the existing evidence we found that various compounds with the stated senolytic activity, including navitoclax, nicotinamide riboside, danazol geldanamycin, ganetespib, fisetin, BCL-XL inhibitors, quercetin, etomoxir, antimycin A, FOXO4-DRI, 17-DMAG turned to be ineffective for the targeted removal of senescent human preadipocytes (fibroblast like precursor cells derived from human adipose tissue) and hMSCs from bone marrow [ 17 19 , 36 , 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…In line with this suggestion, a number of reviews highlighting possible advantageous outcomes of senescent MSCs removal has been published over the past year [29,31,34,35]. Nevertheless, there are only few experimental data regarding this issue [36][37][38][39][40].…”
Section: Introductionmentioning
confidence: 99%
“…In this study, the effects of single-dose SM exposure on HDF were investigated which provides new insight into the pathomechanism of SM-associated wound healing disorder. Previously published research demonstrated that senescent fibroblasts play an important role in chronic wounds and that single-dose SM exposure induces senescence in MSC which may also contribute to chronic wound healing disorders (desJardins-Park et al 2018 ; Rothmiller et al 2021 ). The results of this study hereby confirm for the first time that senescence can also be induced in HDF by SM exposure in a time- and concentration-dependent manner which was detected using different markers of senescence.…”
Section: Discussionmentioning
confidence: 99%
“…In consequence, there are no specific treatment options, neither antidotes nor a prophylaxis available (Etemad et al 2019 ). Recently, Rothmiller et al ( 2021 ) found that SM induces chronic senescence in human mesenchymal stem cells (MSC) which is considered to contribute to the wound healing disorder. As HDF also play a crucial role in wound healing, they might be affected during SM exposure.…”
Section: Introductionmentioning
confidence: 99%
“…The major and important drugs involve in alkylating agents are cyclophosphamide, mechlorethanamine, platinum analogues, procarbazine and other alkylating agents like busulfan, carmustine and lomustine. These drugs are used in breast cancer, ovarian cancer, non-hodgkin lymphoma, chronic lymphocytic leukemia and neuroblastoma (Rothmiller et al, 2021). Its acute and chronic toxicity include nausea, vomiting myelosuppression and hemorrhagic cystitis.…”
Section: Alkylating Agentsmentioning
confidence: 99%